Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 2:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Hypertriglyceridemia, Diabetic Neuropathy
Interventions: omega-3-ethyl esters, Placebo; Drug
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Respiratory Control in Premature Infants
Interventions: Bedside Physiology study, Carotid Body Function Test, Room Air Challenge, Hypoxia Challenge Test, Effects of Nasal Cannula Flow, Magnetic Resonance Imaging, Echocardiogram, Blood Sample; Other · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 1 Day to 28 Days
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pediatric Obesity, Recruitment
Interventions: Pregnant Mothers Interview, Breastfeeding Mothers Interview; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pompe Disease
Interventions: Rituximab, Miglustat; Drug
Lead sponsor: University of Florida; Other
Eligibility: Up to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Parkinson's Disease
Interventions: Blood Sample Collection, Breath Sample Collection; Other
Lead sponsor: Emory University; Other
Eligibility: 25 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Retinal Disease, AMD, Retinal Degeneration, Retinitis Pigmentosa
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 1 Day to 120 Years
Enrollment: 930 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Crohn's Disease
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Epilepsy
Interventions: oxcarbazepine; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 1 Month to 16 Years
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 25
States / cities: Birmingham, Alabama • Mobile, Alabama • Madera, California + 22 more

Conditions: Hearing Loss, Depression
Interventions: Phonak Audeo B-R 90 hearing aid device (Active), Duloxetine or escitalopram, Audeo B-R 90 hearing aid device (Sham); Device · Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 60 Years to 99 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Syphilis
Interventions: Doxycycline 200mg daily for 14 days; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Cytomegalovirus Infection
Interventions: mRNA-1647, Placebo; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 3
States / cities: North Hollywood, California • San Diego, California • Honolulu, Hawaii

Conditions: ACL Injury
Interventions: Magnetic Resonance Imaging (MRI), ACL reconstruction; Diagnostic Test · Procedure
Lead sponsor: Andrews Research & Education Foundation; Other
Eligibility: 14 Years to 24 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Gulf Breeze, Florida

Conditions: Cerebral Palsy
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Months to 24 Months
Enrollment: 100 participants
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Fecal Incontinence in Old Age, Urinary Incontinence in Old Age
Interventions: Mind Over Matter; Healthy Bowels, Healthy Bladder; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 50 Years and older · Female only
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: ACL Tear, ACL Injury, Arthroscopy, Anterior Cruciate Ligament Tear
Interventions: ACL reconstruction with bone marrow, demineralized bone marix, and internal brace augmentation, Standard ACL reconstruction with all inside technique; Procedure
Lead sponsor: Marshall University; Other
Eligibility: 14 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Huntington, West Virginia

Conditions: Anxiety Disorders
Interventions: Diaphragmatic Breathing, Progressive Muscle Relaxation; Behavioral
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 60 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemia, Myelodysplasia-Related
Interventions: Azacitidine, Biospecimen Collection, Bone Marrow Aspiration, Cytarabine, Daunorubicin Hydrochloride, Echocardiography Test, Liposome-encapsulated Daunorubicin-Cytarabine, Multigated Acquisition Scan, Venetoclax; Drug · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 59 Years
Enrollment: 335 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 216
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 175 more

Conditions: Overweight and Obesity, Overweight Adolescents
Interventions: BodyWorks Intervention, Canine Curriculum, Ecological Momentary Assessment, Physical Activity Trackers; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 9 Years to 17 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Leukemia, MDS, Myelofibrosis, Lymphoma
Interventions: Fludarabine, Cyclophosphamide, Mesna, Total Body Irradiation, Hematopoietic stem cell infusion, Tacrolimus, Mycophenolate, G-CSF; Drug · Radiation · Other
Lead sponsor: Rafic Farah, MD; Other
Eligibility: 18 Years to 70 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Depression, Postpartum
Interventions: Sertraline, Placebo, Interpersonal psychotherapy (IPT), Clinical management, Mothercrafting; Drug · Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Iowa City, Iowa • Providence, Rhode Island

Conditions: Chronic Kidney Disease
Interventions: HEPLISAV-B, Engerix-B, Placebo; Biological · Other
Lead sponsor: Dynavax Technologies Corporation; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 521 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Weight Gain, Women's Health, Obesity
Interventions: Weight-gain Prevention, Women's Health; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: ENT Disorder, Nasal Procedures, Nasal Anesthesia, Nasal Mucosa Surgery
Interventions: Cocaine Hydrochloride Nasal Solution; Drug
Lead sponsor: LXO Ireland; Industry
Eligibility: 12 Years to 18 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: Columbia, South Carolina • Lugoff, South Carolina • Newberry, South Carolina

Conditions: Weight Gain, Overweight, Insulin Resistance, Obesity, Diabetes Mellitus, Type 2
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 55 Years
Enrollment: 1,759 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1983
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Lovaza® and Microvascular Function in Type 2 Diabetes

Prematurity-Related Ventilatory Control

The BEACH Interview Study- Pregnant and Breastfeeding Mothers

Observational Study for Subjects With Pompe Disease Undergoing Immune Modulation Therapies

Defining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative Processes

Cell Collection to Study Eye Diseases

Brain-Gut Interactions in Crohn's Disease

Pediatric Epilepsy Study

Treating Hearing Loss to Improve Mood and Cognition in Older Adults

Daily Doxycycline for Early Syphillis

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Andrews Return to Sport ACL Score

Natural History of Cerebral Palsy Prospective Study

Community-Based Continence Promotion: Sustaining Healthy Aging in Place (SHAIP) Through Mind Over Matter (MOM)

The Effect of Fertilized ACL Technique on Outcomes of ACL Reconstruction in Young Adults

Relaxation Treatment for Anxiety in Adults Aged 60 or Older

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Enhancing BodyWorks: A Canine Health Literacy Module

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression

Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) Patients

Preventing Weight Gain in African American Reproductive-Aged Women

Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution and NUMBRINO™ Nasal Solution

Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians